| Bioactivity | THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1]. |
| Name | THR-β agonist 4 |
| CAS | 2673409-25-9 |
| Formula | C16H11Cl2F2N5O6S |
| Molar Mass | 510.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jingye Zhou, et al. Substituted triazinones as thyroid hormone receptor agonists. Patent WO2021143706A1. |
THR-β agonist 4
CAS: 2673409-25-9 F: C16H11Cl2F2N5O6S W: 510.26
THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.